|
|
|
19.05.25 - 23:54
|
XFRA: DIVIDEND/INTEREST INFORMATION - 21.05.2025 - EQUBF_01 (XETRA)
|
|
|
Das Instrument ZCY US2288951088 CRYO-CELL INTL DL-,01 EQUITY wird cum Dividende/Zinsen gehandelt am 20.05.2025 und ex Dividende/Zinsen am 21.05.2025
The instrument ZCY US2288951088 CRYO-CELL INTL DL-,01 EQUITY has its pre-dividend/interest day on 20.05.2025 and its ex-dividend/interest day on 21.05.2025...
|
|
|
|
|
08.05.25 - 23:03
|
Cord Blood Banking Leader Cryo-Cell Announces Cash Dividend (Business Wire)
|
|
|
OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC Symbol: CCEL) (“Cryo-Cell”), the world's first private cord blood bank to separate and store stem cells in 1992, announced today that, as a result of the current economic environment and other capital allocation alternatives, its Board of Directors has approved the payment of a reduced, quarterly cash dividend of $0.15 per share of common stock to be paid to its shareholders of record as of the close of business on May 21, 2025. The dividend is expected to be paid on May 30, 2025. The Board of Directors will continue to evaluate the Company's dividend policy on a regular basis and may change such policy at any time. There is no assurance that future dividends will be paid.
About Cryo-Cell International, Inc.
Founded in 1989, Cryo-Cell International, Inc. is the world's first private cord blood bank. More than 500,000 parents from 87 countries have entrusted Cryo-Cell International with their baby's cord blood an...
|
|
|
15.04.25 - 14:36
|
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2025 Financial Results (Business Wire)
|
|
|
OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL ) (the “Company”), the world's first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal first quarter ended February 28, 2025.
Financial Results
Revenue
The revenues for the first quarter of fiscal 2025 were $7.97 million compared to $7.85 million for the first quarter of fiscal 2024. The revenues for the first quarter of fiscal 2025 consisted of $7.87 million in processing and storage fee revenue, $21,000 in product revenue and approximately $82,000 in public banking revenue compared to $7.81 million in processing and storage fees, approximately $3,000 in product revenue and approximately $44,000 in public banking revenue for the first quarter of fiscal 2024.
Net Income
The Company reported net income of approximately $283,000 or $0.03 per basic and diluted common share for the three months ended February 28, 2025, compared to net income of approximately $556,000, or...
|
|
|
28.02.25 - 23:03
|
Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2024 (Business Wire)
|
|
|
OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem cells in 1992, announced results for its fiscal year ended November 30, 2024.
Financial Results
Revenue
Consolidated revenues for fiscal 2024 were $32.0 million compared to $31.3 million for fiscal 2023. The revenues for fiscal 2024 consisted of $31.6 million in processing and storage fee revenue, $68,000 in product revenue and $367,000 in public banking revenue compared to $30.8 million in processing and storage fee revenue, $66,000 in product revenue and $481,000 in public banking revenue for fiscal 2023.
Net Income (Loss)
The Company reported net income of $402,000 in fiscal 2024 or $0.05 per basic and diluted share, compared to a net loss of $9.5 million in fiscal 2023 or $1.14 per basic and diluted share. For the twelve months ended November 30, 2024, income tax expense was $2.4 million compared to a tax benefit of $3.8 mill...
|
|
|
29.01.25 - 22:18
|
Cord Blood Banking Leader Cryo-Cell Announces Regular Quarterly Cash Dividend and Pause of Strategic Initiatives (Business Wire)
|
|
|
OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC Symbol: CCEL) (“Cryo-Cell”), the world's first private cord blood bank to separate and store stem cells in 1992, announced today that its Board of Directors has approved the payment of a quarterly cash dividend of $0.25 per share of common stock to be paid to its shareholders of record as of the close of business on February 14, 2025. The dividend is expected to be paid on February 28, 2025. The Board of Directors will continue to evaluate the Company's dividend policy on a regular basis and may change such policy at any time. There is no assurance that future dividends will be paid.
The Company also announced that it has paused its strategic initiatives relating to the possible sale or merger of the Company.
About Cryo-Cell International, Inc.
Founded in 1989, Cryo-Cell International, Inc. is the world's first private cord blood bank. More than 500,000 parents from 87 countries have entrusted Cryo-Cell Internationa...
|
|
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
